BR112012026860A2 - composição farmacêutica sólida para neutralizar ácido estomacal - Google Patents

composição farmacêutica sólida para neutralizar ácido estomacal

Info

Publication number
BR112012026860A2
BR112012026860A2 BR112012026860A BR112012026860A BR112012026860A2 BR 112012026860 A2 BR112012026860 A2 BR 112012026860A2 BR 112012026860 A BR112012026860 A BR 112012026860A BR 112012026860 A BR112012026860 A BR 112012026860A BR 112012026860 A2 BR112012026860 A2 BR 112012026860A2
Authority
BR
Brazil
Prior art keywords
pharmaceutical composition
solid pharmaceutical
stomach acid
neutralize stomach
neutralize
Prior art date
Application number
BR112012026860A
Other languages
English (en)
Inventor
Larsen Finn
Richard Pedersen Jens
Original Assignee
S Biotek Holding Aps
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by S Biotek Holding Aps filed Critical S Biotek Holding Aps
Publication of BR112012026860A2 publication Critical patent/BR112012026860A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/734—Alginic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A61K33/08—Oxides; Hydroxides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/14—Alkali metal chlorides; Alkaline earth metal chlorides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0065—Forms with gastric retention, e.g. floating on gastric juice, adhering to gastric mucosa, expanding to prevent passage through the pylorus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Nutrition Science (AREA)
  • Molecular Biology (AREA)
  • Physiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
BR112012026860A 2010-04-23 2011-04-18 composição farmacêutica sólida para neutralizar ácido estomacal BR112012026860A2 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DKPA201070167 2010-04-23
US35143710P 2010-06-04 2010-06-04
PCT/DK2011/050125 WO2011131203A2 (en) 2010-04-23 2011-04-18 A solid pharmaceutical composition for neutralizing stomach acid

Publications (1)

Publication Number Publication Date
BR112012026860A2 true BR112012026860A2 (pt) 2018-06-05

Family

ID=44626011

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112012026860A BR112012026860A2 (pt) 2010-04-23 2011-04-18 composição farmacêutica sólida para neutralizar ácido estomacal

Country Status (11)

Country Link
US (1) US9186409B2 (pt)
EP (1) EP2560732A2 (pt)
JP (2) JP2013525313A (pt)
KR (1) KR20130091250A (pt)
CN (1) CN102844077A (pt)
AU (1) AU2011242177B8 (pt)
BR (1) BR112012026860A2 (pt)
CA (1) CA2795521A1 (pt)
EA (1) EA024050B1 (pt)
IL (1) IL222625A0 (pt)
WO (1) WO2011131203A2 (pt)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8663714B2 (en) 2009-11-26 2014-03-04 D.Xign Limited Appetite regulating dietary supplement
JP6245677B2 (ja) * 2012-01-20 2017-12-13 ニプロ株式会社 口腔内崩壊錠
EP3288556A4 (en) * 2015-04-29 2018-09-19 Dexcel Pharma Technologies Ltd. Orally disintegrating compositions
ITUB20152623A1 (it) * 2015-07-30 2017-01-30 Neilos S R L Composizione per uso orale nel trattamento dei disturbi o malattia da reflusso gastroesofageo
JP6498158B2 (ja) * 2016-07-11 2019-04-10 ニプロ株式会社 口腔内崩壊錠
CA3224263A1 (en) * 2021-07-05 2023-01-12 Reflux Gourmet Llc Method for neutralizing stomach acid using alginate, polylysine, and seed preservatives

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1524740A (en) 1976-11-09 1978-09-13 Reckitt & Colmann Prod Ltd Pharmaceutical compositions for use in the suppression of gastric reflux
GB1566609A (en) * 1977-03-10 1980-05-08 Reckitt & Colmann Prod Ltd Pharmaceutical compositions containing cholestyramine and alginic acid
GB1601833A (en) 1978-02-06 1981-11-04 Wellcome Found Antacid formulation
EP0484106A1 (en) * 1990-11-01 1992-05-06 Merck & Co. Inc. Controlled release formulations
CZ225893A3 (en) * 1991-04-04 1994-04-13 Procter & Gamble Chewing antacid preparation
NZ274901A (en) * 1993-10-29 1997-03-24 Reckitt & Colmann Prod Ltd Chewable gelatin capsule for the treatment of gastric reflux or peptic ulceration comprising polymeric material, carbonate or bicarbonate salt and oil or hydrophilic based liquid vehicle
EP0761227A4 (en) * 1994-06-06 1998-06-10 Yamanouchi Pharma Co Ltd SOLID ANTAZID AND METHOD FOR THE PRODUCTION THEREOF
GB2298365B (en) 1995-03-03 1997-05-07 Reckitt & Colmann Prod Ltd A liquid pharmaceutical composition alginate and potassium bicarbonate
US6645988B2 (en) 1996-01-04 2003-11-11 Curators Of The University Of Missouri Substituted benzimidazole dosage forms and method of using same
SE9600071D0 (sv) 1996-01-08 1996-01-08 Astra Ab New oral formulation of two active ingredients I
EP0979091A1 (en) 1997-04-30 2000-02-16 Reckitt Benckiser Healthcare (UK) Limited Pourable alginate compositions
GB9708773D0 (en) 1997-04-30 1997-06-25 Reckitt & Colmann Prod Ltd Organic compositions
GB9812426D0 (en) 1998-06-10 1998-08-05 Reckitt & Colmann Prod Ltd Improvements in or relating to organic compositions
GB0012094D0 (en) 2000-05-19 2000-07-12 Reckitt & Colmann Prod Ltd Pharmaceutical compositions
GB2384986B (en) * 2002-02-12 2004-01-07 Reckitt Benckiser Healthcare Compositions for the treatment of disorders of the upper gastrointestinal tract
US6703044B1 (en) 2002-10-25 2004-03-09 Dexcel Pharma Tech, Ltd Venlafaxine formulations
MXPA06000417A (es) 2003-07-10 2006-03-17 Smithkline Beecham Corp Composiciones farmaceuticas.
US7384921B2 (en) 2004-02-20 2008-06-10 Enanta Pharmaceuticals, Inc. Polymorphic forms of 6-11 bicyclic ketolide derivatives
AR056062A1 (es) * 2006-06-05 2007-09-19 Bago Sa Labor Composicion farmaceutica antiacida en forma de polvo, preparacion farmaceutica que la comprende y proceso para su preparacion
DE102006037298A1 (de) 2006-08-08 2008-02-14 Maria Clementine Martin Klosterfrau Vertriebsgesellschaft Mbh Pharmazeutische Zusammensetzung, insbesondere Antazidum
GB0814376D0 (en) 2008-08-06 2008-09-10 Reckitt Benckiser Healthcare Formulation

Also Published As

Publication number Publication date
US20130210762A1 (en) 2013-08-15
EA201291022A1 (ru) 2013-09-30
KR20130091250A (ko) 2013-08-16
WO2011131203A3 (en) 2012-09-13
US9186409B2 (en) 2015-11-17
JP2016166220A (ja) 2016-09-15
WO2011131203A2 (en) 2011-10-27
AU2011242177B8 (en) 2015-06-04
EA024050B1 (ru) 2016-08-31
IL222625A0 (en) 2012-12-31
CN102844077A (zh) 2012-12-26
EP2560732A2 (en) 2013-02-27
JP2013525313A (ja) 2013-06-20
CA2795521A1 (en) 2011-10-27
AU2011242177A1 (en) 2012-10-25
AU2011242177B2 (en) 2015-05-14

Similar Documents

Publication Publication Date Title
SMT201700008B (it) Composizione farmaceutica
SMT201600350B (it) Composizioni farmaceutiche
SMT201700095B (is) Composizioni farmaceutiche per inalazione
DK3246018T3 (da) Farmaceutisk sammensætning
DK2694038T3 (da) Farmaceutisk sammensætning
DK3284467T3 (da) Nikotinholdige farmaceutiske sammensætninger
CO6852076A2 (es) Composiciones farmacéuticas inhalables
DK3097925T3 (da) Farmaceutisk sammensætning
BR112014003052A2 (pt) composições farmacêuticas
BRPI1004940A2 (pt) composição farmacêutica
EE201300005A (et) Ravimkoostis
CO6930367A2 (es) Composiciones farmaceúticas
BRPI1015939A2 (pt) composição farmacêutica
BRPI1012539A2 (pt) composições farmacêuticas
GT201200303A (es) Formulaciones farmacéuticas
BRPI1011650A2 (pt) composições sólidas compreendendo ácido 5-aminolevulínico
DK2654736T3 (da) Hidtil ukendt farmaceutisk sammensætning
BR112012004080A2 (pt) composições farmacêuticas para tratar ibd
IT1394400B1 (it) Composizioni farmaceutiche
DK2542224T3 (da) Oral farmaceutisk sammensætning indeholdende dabigatranetexilat
CO6801722A2 (es) Composiciones farmacéuticas
SMT201500005B (it) Composizione framaceutica inalabile
BR112012026860A2 (pt) composição farmacêutica sólida para neutralizar ácido estomacal
BR112015003116A2 (pt) preparação farmacêutica sólida contendo levotiroxina
BR112012003149A2 (pt) composição farmacêutica

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 8A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO ARQUIVAMENTO PUBLICADO NA RPI 2510 DE 12/02/2019.